Home > News Item Detail
Headache in the News ArchiveDG News -- Novel Inhaled Formulation of Dihydroergotamine Effective for a Broad Spectrum of Migraine
2009 Sep 16 PHILADELPHIA -- September 15, 2009 -- MAP0004, a novel orally inhaled formulation of dihydroergotamine (DHE) currently under development, may be effective in treating a broad spectrum of migraine,
http://www.docguide.com/news/content.nsf/news/852576140048867A8525763200531FF8 Categories: Medicated Treatments |
Find a headache specialist near you:
From NHF HeadLines
Take Control of Your Headaches - Issue 175
NHF Features